Koster
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Take-off WO fase 1 - Haalbaarheidsstudies 2025 TTW 1, SupraVision: regenerative therapy for blinding retinal diseases, 22378, 2025, 26 Dec 2025
Sources: openalex.org
Lead investigator
Sources: openalex.org
Take-off WO fase 1 - Haalbaarheidsstudies 2025 TTW 1, SupraVision: regenerative therapy for blinding retinal diseases, 22378, 2025, 26 Dec 2025
Sources: openalex.org